AxoGen Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
AXGN Nasdaq 3845 https://www.axogeninc.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AxoGen Inc

AxoGen, Inc. (NASDAQ:AXGN) Q4 2022 Earnings Call Transcript - Mar 17th, 2023 8:31 am
AxoGen Full Year 2022 Earnings: EPS Beats Expectations - Mar 16th, 2023 10:30 am
Q4 2022 AxoGen Inc Earnings Call - Mar 15th, 2023 3:23 am
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results - Mar 14th, 2023 11:00 am
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel - Mar 6th, 2023 12:00 pm
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023 - Mar 2nd, 2023 9:00 pm
AxoGen (NASDAQ:AXGN) investors are sitting on a loss of 76% if they invested five years ago - Mar 1st, 2023 2:21 pm
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer - Feb 13th, 2023 12:00 pm
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022 - Jan 9th, 2023 12:00 pm
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits - Jan 5th, 2023 12:00 pm
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference - Jan 4th, 2023 12:00 pm
AxoGen, Inc. (NASDAQ:AXGN) is favoured by institutional owners who hold 65% of the company - Jan 1st, 2023 1:52 pm
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation - Dec 19th, 2022 12:00 pm
Here's Why "Trend" Investors Would Love Betting on AxoGen (AXGN) - Nov 11th, 2022 1:50 pm
AxoGen (AXGN) Reports Q3 Loss, Tops Revenue Estimates - Nov 8th, 2022 1:15 pm
Edited Transcript of AXGN.OQ earnings conference call or presentation 8-Nov-22 1:00pm GMT - Nov 8th, 2022 1:00 pm
Axogen, Inc Reports 2022 Third Quarter Financial Results - Nov 8th, 2022 12:00 pm
Axogen to Participate at Upcoming Investor Conferences - Nov 3rd, 2022 8:00 pm
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D. - Oct 31st, 2022 11:00 am
AxoGen (AXGN) Upgraded to Buy: Here's What You Should Know - Oct 27th, 2022 4:00 pm